RPGLIFE — RPG Life Sciences Balance Sheet
0.000.00%
- IN₹34.55bn
- IN₹31.84bn
- IN₹6.53bn
- 79
- 16
- 75
- 61
Annual balance sheet for RPG Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 404 | 698 | 1,162 | 1,259 | 2,713 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 725 | 460 | 375 | 643 | 868 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,759 | 2,069 | 2,641 | 2,981 | 4,653 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 879 | 1,001 | 1,163 | 1,818 | 1,651 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 3,034 | 3,446 | 4,194 | 5,129 | 6,578 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 797 | 801 | 1,028 | 1,310 | 1,198 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 869 | 888 | 1,118 | 1,380 | 1,273 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 2,165 | 2,558 | 3,076 | 3,749 | 5,305 |
Total Liabilities & Shareholders' Equity | 3,034 | 3,446 | 4,194 | 5,129 | 6,578 |
Total Common Shares Outstanding |